PT  - JOURNAL ARTICLE
AU  - Tak, Divyanshu
AU  - Garomsa, Biniam A.
AU  - Zapaishchykova, Anna
AU  - Ye, Zezhong
AU  - Vajapeyam, Sri
AU  - Mahootiha, Maryam
AU  - Climent Pardo, Juan Carlos
AU  - Smith, Ceilidh
AU  - Familiar, Ariana M.
AU  - Chaunzwa, Tafadzwa
AU  - Liu, Kevin X.
AU  - Prabhu, Sanjay
AU  - Bandopadhayay, Pratiti
AU  - Nabavizadeh, Ali
AU  - Mueller, Sabine
AU  - Aerts, Hugo JWL
AU  - Haas-Kogan, Daphne
AU  - Poussaint, Tina Y.
AU  - Kann, Benjamin H.
TI  - Longitudinal risk prediction for pediatric glioma with temporal deep learning
AID  - 10.1101/2024.06.04.24308434
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.06.04.24308434
4099  - http://medrxiv.org/content/early/2024/06/28/2024.06.04.24308434.short
4100  - http://medrxiv.org/content/early/2024/06/28/2024.06.04.24308434.full
AB  - Pediatric glioma recurrence can cause morbidity and mortality; however, recurrence pattern and severity are heterogeneous and challenging to predict with established clinical and genomic markers. Resultingly, almost all children undergo frequent, long-term, magnetic resonance (MR) brain surveillance regardless of individual recurrence risk. Deep learning analysis of longitudinal MR may be an effective approach for improving individualized recurrence prediction in gliomas and other cancers but has thus far been infeasible with current frameworks. Here, we propose a self-supervised, deep learning approach to longitudinal medical imaging analysis, temporal learning, that models the spatiotemporal information from a patient’s current and prior brain MRs to predict future recurrence. We apply temporal learning to pediatric glioma surveillance imaging for 715 patients (3,994 scans) from four distinct clinical settings. We find that longitudinal imaging analysis with temporal learning improves recurrence prediction performance by up to 41% compared to traditional approaches, with improvements in performance in both low- and high-grade glioma. We find that recurrence prediction accuracy increases incrementally with the number of historical scans available per patient. Temporal deep learning may enable point-of-care decision-support for pediatric brain tumors and be adaptable more broadly to patients with other cancers and chronic diseases undergoing surveillance imaging.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by NIH/NCI: U54 CA274516 NIH/NCI: P50 CA165962 Botha-Chan Low Grade Glioma ConsortiumAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted in accordance with the Declaration of Helsinki guidelines. Institutional Review Board (IRB) of Dana-Farber/Boston Childrens/Harvard Cancer Center gave ethical approval for this work. Waiver of consent was obtained from IRB prior to research initiation due to public datasets or retrospective study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data supporting the findings described in this manuscript are available in the article, in the Supplementary Information, and from the corresponding author upon request. The CBTN data is available upon request at “ https://cbtn.org/ “. The DFCI/BCH and RadART brain tumor dataset contains private hospital data that is controlled due to privacy concerns. Access to the derived dataset will be considered upon request to the corresponding author (Benjamin H. Kann, M.D., email: Benjamin_Kann@dfci.harvard.edu, timeframe for response 2 weeks).pLGGpediatric Low-Grade GliomaCNNConvolutional neural networkAUCArea under the curveDLDeep learningMRIMagnetic resonance imagingSSLSelf-supervised LearningMHSAMulti-headed self-attentionLSTMLong short-term memory networkFCFully connected layerHGGHigh-grade gliomaAIArtificial Intelligence